Literature DB >> 2894566

Craniopharyngioma recurrence and growth hormone therapy.

P E Clayton, D A Price, S M Shalet, H R Gattemaneni.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2894566     DOI: 10.1016/s0140-6736(88)91434-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Growth and endocrine sequelae of craniopharyngioma.

Authors:  C J DeVile; D B Grant; R D Hayward; R Stanhope
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

2.  Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.

Authors:  C R Buchanan; M A Preece; R D Milner
Journal:  BMJ       Date:  1991-04-06

Review 3.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

Review 4.  A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma.

Authors:  Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta
Journal:  Childs Nerv Syst       Date:  2012-10-23       Impact factor: 1.475

5.  Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.

Authors:  Michal Cohen; Sharon Guger; Jill Hamilton
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-28       Impact factor: 5.555

6.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

Review 7.  Cancer risk following growth hormone use in childhood: implications for current practice.

Authors:  Amanda L Ogilvy-Stuart; Helena Gleeson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.